Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 10134-10145

  Graw, Frederik ^a,b   Regoes, Roland R ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; THEORETICAL MODEL; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL4; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; MODELS, THEORETICAL; VIRAL LOAD;

EID: 84921958910     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00647-14     Document Type: Article

References (78)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
2. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
3. Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. 1999. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 189:1555-1564. http://dx.doi.org/10.1084/jem.189.10.1555.
4. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. http://dx.doi.org/10.1128/JVI.77.8.4911-4927.2003.
5. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. 1999. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998. http://dx.doi.org/10.1084/jem.189.6.991.
6. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+lymphocytes. Science 283:857-860. http://dx.doi.org/10.1126/science.283.5403.857.
7. Makedonas G, Betts MR. 2011. Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV. Immunol. Rev. 239:109-124. http://dx.doi.org/10.1111/j.1600-065X.2010.00968.x.
8. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96. http://dx.doi.org/10.1126/science.274.5284.94.
9. Moss PA, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. U. S. A. 92:5773-5777. http://dx.doi.org/10.1073/pnas.92.13.5773.
10. Wilson JD, Ogg GS, Allen RL, Goulder PJ, Kelleher A, Sewell AK, O'Callaghan CA, Rowland-Jones SL, Callan MF, McMichael AJ. 1998. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785-790. http://dx.doi.org/10.1084/jem.188.4.785.
11. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN, Kelleher T, Emery S, Cooper D, Barroso P, Schechter M, Kalichman A, Kallas E, Bruneau J, Loutfy M, Tyndale M, Donastorg Y, Koenig E, Joseph P, Pape J, Figueroa P, Casapia M, Cabello R, Sanchez J, Leon R, Zorrilla C, Frew P, Mulligan M, Goepfert P, Baden L, Mayer K, Novak R, Judson F, Lee P, Tyring S, Brown S, Santiago S, Daskalakis D, Hammer S, Koblin B, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893. http://dx.doi.org/10.1016/S0140-6736(08)61591-3.
12. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789. http://dx.doi.org/10.1182/blood-2005-12-4818.
13. Lieberman J, Shankar P, Manjunath N, Andersson J. 2001. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98:1667-1677. http://dx.doi.org/10.1182/blood.V98.6.1667.
14. Shin H, Wherry EJ. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19:408-415. http://dx.doi.org/10.1016/j.coi.2007.06.004.
15. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687. http://dx.doi.org/10.1038/nature04444.
16. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L, Vanderford TH, Chennareddi L, Silvestri G, Freeman GJ, Ahmed R, Amara RR. 2009. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458: 206-210. http://dx.doi.org/10.1038/nature07662.
17. Rehr M, Cahenzli J, Haas A, Price DA, Gostick E, Huber M, Karrer U, Oxenius A. 2008. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 82:3391-3404. http://dx.doi.org/10.1128/JVI.02383-07.
18. Schellens IM, Borghans JA, Jansen CA, De Cuyper IM, Geskus RB, van Baarle D, Miedema F. 2008. Abundance of early functional HIV-specific CD8+T cells does not predict AIDS-free survival time. PLoS One 3:e2745. http://dx.doi.org/10.1371/journal.pone.0002745.
19. Krakauer DC, Nowak M. 1999. T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc. Biol. Sci. 266:1069-1075. http://dx.doi.org/10.1098/rspb.1999.0745.
20. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. 1996. HIV-1 entry into CD4+cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673. http://dx.doi.org/10.1038/381667a0.
21. Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML. 2000. CD8+T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc. Natl. Acad. Sci. U. S. A. 97:3503-3508. http://dx.doi.org/10.1073/pnas.97.7.3503.
22. Janeway CA, Travers P, Walport M, Shlomchik M. 1996. Immunobiology. Garland Publishing, New York, NY.
23. Hammer SM, Gillis JM, Groopman JE, Rose RM. 1986. In vitro modification of human immunodeficiency virus infection by granulocytemacrophage colony-stimulating factor and gamma interferon. Proc. Natl. Acad. Sci. U. S. A. 83:8734-8738. http://dx.doi.org/10.1073/pnas.83.22.8734.
24. Mackewicz CE, Blackbourn DJ, Levy JA. 1995. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. U. S. A. 92:2308-2312. http://dx.doi.org/10.1073/pnas.92.6.2308.
25. Walker CM, Moody DJ, Stites DP, Levy JA. 1986. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566. http://dx.doi.org/10.1126/science.2431484.
26. Walker CM, Levy JA. 1989. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66:628-630.
27. Levy JA. 2003. The search for the CD8+cell anti-HIV factor (CAF). Trends Immunol. 24:628-632. http://dx.doi.org/10.1016/j.it.2003.10.005.
28. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815. http://dx.doi.org/10.1126/science.270.5243.1811.
29. Nowak MA, May RM. 2000. Virus dynamics. Oxford University Press, Oxford, United Kingdom.
30. Regoes RR, Barber DL, Ahmed R, Antia R. 2007. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 104:1599-1603. http://dx.doi.org/10.1073/pnas.0508830104.
31. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122. http://dx.doi.org/10.1038/373117a0.
32. Althaus CL, De Boer RJ. 2008. Dynamics of immune escape during HIV/SIV infection. PLoS Comput. Biol. 4:e1000103. http://dx.doi.org/10.1371/journal.pcbi.1000103.
33. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, Markowitz M, Moore JP, Perelson AS, Ho DD. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:1782-1785. http://dx.doi.org/10.1016/S0140-6736(99)02035-8.
34. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, Koup RA, Picker LJ. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991. http://dx.doi.org/10.1128/JVI.75.24.11983-11991.2001.
35. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Shuying L, Connors M. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068. http://dx.doi.org/10.1038/ni845.
36. Bodman-Smith MD, Williams I, Johnstone R, Boylston A, Lydyard PM, Zumla A. 2002. T cell receptor usage in patients with non-progressing HIV infection. Clin. Exp. Immunol. 130:115-120. http://dx.doi.org/10.1046/j.1365-2249.2002.01944.x.
37. Trepel F. 1974. Number and distribution of lymphocytes in man. A critical analysis. Klin. Wochenschr. 52:511-515. http://dx.doi.org/10.1007/BF01468720.
38. De Odorico I, Spaulding KA, Pretorius DH, Lev-Toaff AS, Bailey TB, Nelson TR. 1999. Normal splenic volumes estimated using threedimensional ultrasonography. J. Ultrasound Med. 18:231-236.
39. Fleury S, de Boer RJ, Rizzardi GP, Wolthers KC, Otto SA, Welbon CC, Graziosi C, Knabenhans C, Soudeyns H, Bart PA, Gallant S, Corpataux JM, Gillet M, Meylan P, Schnyder P, Meuwly JY, Spreen W, Glauser MP, Miedema F, Pantaleo G. 1998. Limited CD4+T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat. Med. 4:794-801. http://dx.doi.org/10.1038/nm0798-794.
40. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lord CI, Forman MA, Letvin NL. 1999. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virusinfected rhesus monkeys. J. Virol. 73:1573-1579.
41. Ngai P, McCormick S, Small C, Zhang X, Zganiacz A, Aoki N, Xing Z. 2007. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovisBCGinfection. Infect. Immun. 75:2244-2252. http://dx.doi.org/10.1128/IAI.00024-07.
42. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:5037-5038. http://dx.doi.org/10.1128/JVI.77.8.5037-5038.2003.
43. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126. http://dx.doi.org/10.1038/373123a0.
44. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586. http://dx.doi.org/10.1126/science.271.5255.1582.
45. Asquith B, Edwards CTT, Lipsitch M, McLean AR. 2006. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 4:e90. http://dx.doi.org/10.1371/journal.pbio.0040090.
46. Asquith B, Mosley AJ, Barfield A, Marshall SE, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CR. 2005. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J. Gen. Virol. 86:1515-1523. http://dx.doi.org/10.1099/vir.0.80766-0.
47. Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H. 1992. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein. J. Virol 66:132-138.
48. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH, Jr, Erice A, Perelson AS. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274:985-989. http://dx.doi.org/10.1126/science.274.5289.985.
49. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L. 2007. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 104:19079-19084. http://dx.doi.org/10.1073/pnas.0707449104.
50. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, Grossman Z, Dybul M, Oxenius A, Price DA, Connors M, Koup RA. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98. http://dx.doi.org/10.1038/417095a.
51. Simpson EH. 1949. Measurement of diversity. Nature 163:688. http://dx.doi.org/10.1038/163688a0.
52. Lichterfeld M, Yu XG, Waring MT, Mui SK, Johnston MN, Cohen D, Addo MM, Zaunders J, Alter G, Pae E, Strick D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. 2004. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferongamma and tumor necrosis factor-alpha. Blood 104:487-494. http://dx.doi.org/10.1182/blood-2003-12-4341.
53. Sandberg JK, Fast NM, Nixon DF. 2001. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J. Immunol. 167:181-187. http://dx.doi.org/10.4049/jimmunol.167.1.181.
54. Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, Lawson B, Miller MD, Else J, Pandrea I, Estes JD, Apetrei C, Schmitz JE, Ribeiro RM, Perelson AS, Silvestri G. 2010. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog. 6:e1000747. http://dx.doi.org/10.1371/journal.ppat.1000747.
55. Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S. 2010. In vivo CD8+ T-cell suppression of SIV viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog. 6:e1000748. http://dx.doi.org/10.1371/journal.ppat.1000748.
56. Elemans M, Seich Al Basatena NK, Klatt NR, Gkekas C, Silvestri G, Asquith B. 2011. Why don't CD8+ T cells reduce the lifespan of SIVinfected cells in vivo? PLoS Comput. Biol. 7:e1002200. http://dx.doi.org/10.1371/journal.pcbi.1002200.
57. Elemans M, Thiebaut R, Kaur A, Asquith B. 2011. Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection. PLoS Comput. Biol. 7:e1001103. http://dx.doi.org/10.1371/journal.pcbi.1001103.
58. Ganusov VV, Antia R. 2005. Pathology during acute infections: contributions of intracellular pathogens and the CTL response. Biol. Lett. 1:239-242. http://dx.doi.org/10.1098/rsbl.2004.0276.
59. Wodarz D, Krakauer DC. 2000. Defining CTL-induced pathology: implications for HIV. Virology 274:94-104. http://dx.doi.org/10.1006/viro.2000.0399.
60. Wodarz D, Christensen JP, Thomsen AR. 2002. The importance of lytic and nonlytic immune response in viral infections. Trends Immunol. 23: 194-200. http://dx.doi.org/10.1016/S1471-4906(02)02189-0.
61. Davenport MP, Zhang L, Bagchi A, Fridman A, Fu TM, Schleif W, Shiver JW, Ribeiro RM, Perelson AS. 2005. High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T-cell expansion but improved virus control. J. Virol. 79:10059-10062. http://dx.doi.org/10.1128/JVI.79.15.10059-10062.2005.
62. Davenport MP, Ribeiro RM, Perelson AS. 2004. Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J. Virol. 78:10096-10103. http://dx.doi.org/10.1128/JVI.78.18.10096-10103.2004.
63. Agnellini P, Wolint P, Rehr M, Cahenzli J, Karrer U, Oxenius A. 2007. Impaired NFAT nuclear translocation results in split exhaustion of virusspecific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 104:4565-4570. http://dx.doi.org/10.1073/pnas.0610335104.
64. Graw F, Richter K, Oxenius A, Regoes RR. 2011. Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection. Proc. Biol. Sci. 278:3395-3402. http://dx.doi.org/10.1098/rspb.2011.0453.
65. Ganusov VV, Lukacher AE, Byers AM. 2010. Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection. Virology 405:193-200. http://dx.doi.org/10.1016/j.virol.2010.05.029.
66. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen IS. 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241:1673-1675. http://dx.doi.org/10.1126/science.3047875.
67. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137-1151. http://dx.doi.org/10.1084/jem.169.3.1137.
68. Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, Fauci AS. 1992. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176:739-750. http://dx.doi.org/10.1084/jem.176.3.739.
69. Yamamoto JK, Barre-Sinoussi F, Bolton V, Pedersen NC, Gardner MB. 1986. Human alpha-and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J. Interferon Res. 6:143-152. http://dx.doi.org/10.1089/jir.1986.6.143.
70. Yamada O, Hattori N, Kurimura T, Kita M, Kishida T. 1988. Inhibition of growth of HIV by human natural interferon in vitro. AIDS Res. Hum. Retroviruses 4:287-294. http://dx.doi.org/10.1089/aid.1988.4.287.
71. Feldmann M. 2008. Many cytokines are very useful therapeutic targets in disease. J. Clin. Invest. 118:3533-3536. http://dx.doi.org/10.1172/JCI37346.
72. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700. http://dx.doi.org/10.1146/annurev.immunol.17.1.657.
73. Seich Al Basatena NK, Chatzimichalis K, Graw F, Frost SD, Regoes RR, Asquith B. 2013. Can non-lytic CD8+ T cells drive HIV-1 escape? PLoS Pathog. 9:e1003656. http://dx.doi.org/10.1371/journal.ppat.1003656.
74. Gardiner D, Lalezari J, Lawitz E, DiMicco M, Ghalib R, Reddy KR, Chang KM, Sulkowski M, Marro SO, Anderson J, He B, Kansra V, McPhee F, Wind-Rotolo M, Grasela D, Selby M, Korman AJ, Lowy I. 2013. A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection. PLoS One 8:e63818. http://dx.doi.org/10.1371/journal.pone.0063818.
75. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102. http://dx.doi.org/10.1212/WNL.37.7.1097.
76. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8:247-258. http://dx.doi.org/10.1038/nri2274.
77. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13:843-850. http://dx.doi.org/10.1038/nm1592.
78. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. 2007. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81:8468-8476. http://dx.doi.org/10.1128/JVI.00228-07.